nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—SLC22A5—Dactinomycin—melanoma	0.212	0.373	CbGbCtD
Dopamine—CYP1A2—Carmustine—melanoma	0.117	0.206	CbGbCtD
Dopamine—CYP1A2—Vemurafenib—melanoma	0.0926	0.163	CbGbCtD
Dopamine—CYP2D6—Vemurafenib—melanoma	0.0763	0.134	CbGbCtD
Dopamine—CYP1A2—Dacarbazine—melanoma	0.071	0.125	CbGbCtD
Dopamine—DRD5—eyelid—melanoma	0.0204	0.337	CbGeAlD
Dopamine—Isoprenaline—MAPK1—melanoma	0.00329	0.527	CrCbGaD
Dopamine—COMT—hair follicle—melanoma	0.00314	0.0516	CbGeAlD
Dopamine—HTR7—endothelium—melanoma	0.00221	0.0365	CbGeAlD
Dopamine—HTR7—blood vessel—melanoma	0.00204	0.0336	CbGeAlD
Dopamine—DBH—head—melanoma	0.00168	0.0277	CbGeAlD
Dopamine—COMT—eye—melanoma	0.00157	0.0258	CbGeAlD
Dopamine—Mesalazine—PPARG—melanoma	0.00153	0.245	CrCbGaD
Dopamine—HTR7—neck—melanoma	0.00146	0.024	CbGeAlD
Dopamine—MAOA—neck—melanoma	0.0014	0.023	CbGeAlD
Dopamine—DRD3—head—melanoma	0.00138	0.0227	CbGeAlD
Dopamine—COMT—skin of body—melanoma	0.00136	0.0224	CbGeAlD
Dopamine—DRD5—head—melanoma	0.00129	0.0213	CbGeAlD
Dopamine—COMT—mammalian vulva—melanoma	0.00124	0.0204	CbGeAlD
Dopamine—DBH—lymph node—melanoma	0.00118	0.0194	CbGeAlD
Dopamine—SLC22A3—mammalian vulva—melanoma	0.00104	0.0172	CbGeAlD
Dopamine—MAOA—retina—melanoma	0.00103	0.0169	CbGeAlD
Dopamine—DRD2—eye—melanoma	0.00103	0.0169	CbGeAlD
Dopamine—DRD2—retina—melanoma	0.00102	0.0168	CbGeAlD
Dopamine—DRD1—head—melanoma	0.000987	0.0163	CbGeAlD
Dopamine—MAOB—mammalian vulva—melanoma	0.000966	0.0159	CbGeAlD
Dopamine—SLC22A5—retina—melanoma	0.000948	0.0156	CbGeAlD
Dopamine—COMT—head—melanoma	0.000889	0.0146	CbGeAlD
Dopamine—SLC22A5—skin of body—melanoma	0.000832	0.0137	CbGeAlD
Dopamine—MAOA—mammalian vulva—melanoma	0.000824	0.0136	CbGeAlD
Dopamine—SLC6A3—head—melanoma	0.000793	0.0131	CbGeAlD
Dopamine—Epinephrine—TNF—melanoma	0.000782	0.125	CrCbGaD
Dopamine—SLC22A1—head—melanoma	0.000782	0.0129	CbGeAlD
Dopamine—ADRB1—head—melanoma	0.000753	0.0124	CbGeAlD
Dopamine—SLC22A3—head—melanoma	0.000747	0.0123	CbGeAlD
Dopamine—SLC6A4—head—melanoma	0.000727	0.012	CbGeAlD
Dopamine—MAOB—head—melanoma	0.000691	0.0114	CbGeAlD
Dopamine—HTR1A—head—melanoma	0.000646	0.0106	CbGeAlD
Dopamine—Mesalazine—PTGS2—melanoma	0.000645	0.103	CrCbGaD
Dopamine—SLC6A2—head—melanoma	0.00064	0.0105	CbGeAlD
Dopamine—COMT—lymph node—melanoma	0.000622	0.0102	CbGeAlD
Dopamine—HTR7—head—melanoma	0.000617	0.0102	CbGeAlD
Dopamine—MAOA—head—melanoma	0.00059	0.00971	CbGeAlD
Dopamine—DRD2—head—melanoma	0.000583	0.0096	CbGeAlD
Dopamine—SLC22A3—lymph node—melanoma	0.000523	0.00861	CbGeAlD
Dopamine—MAOB—lymph node—melanoma	0.000484	0.00797	CbGeAlD
Dopamine—SLC6A2—lymph node—melanoma	0.000448	0.00738	CbGeAlD
Dopamine—MAOA—lymph node—melanoma	0.000413	0.0068	CbGeAlD
Dopamine—SLC22A5—lymph node—melanoma	0.00038	0.00626	CbGeAlD
Dopamine—CYP2D6—head—melanoma	0.000351	0.00577	CbGeAlD
Dopamine—Azotaemia—Carmustine—melanoma	0.000333	0.0875	CcSEcCtD
Dopamine—Atrial fibrillation—Vemurafenib—melanoma	0.000257	0.0675	CcSEcCtD
Dopamine—Necrosis—Dactinomycin—melanoma	0.000242	0.0635	CcSEcCtD
Dopamine—Extravasation—Bleomycin—melanoma	0.000233	0.0612	CcSEcCtD
Dopamine—Menorrhagia—Temozolomide—melanoma	0.000232	0.0609	CcSEcCtD
Dopamine—Necrosis—Carmustine—melanoma	0.000226	0.0594	CcSEcCtD
Dopamine—Extravasation—Dactinomycin—melanoma	0.000218	0.0571	CcSEcCtD
Dopamine—Extravasation—Carmustine—melanoma	0.000204	0.0534	CcSEcCtD
Dopamine—Necrosis—Docetaxel—melanoma	0.000145	0.0382	CcSEcCtD
Dopamine—Extravasation—Docetaxel—melanoma	0.000131	0.0343	CcSEcCtD
Dopamine—Atrial fibrillation—Docetaxel—melanoma	8.74e-05	0.023	CcSEcCtD
Dopamine—Vomiting—Vemurafenib—melanoma	7.62e-05	0.02	CcSEcCtD
Dopamine—Headache—Vemurafenib—melanoma	7.51e-05	0.0197	CcSEcCtD
Dopamine—Nausea—Vemurafenib—melanoma	7.12e-05	0.0187	CcSEcCtD
Dopamine—Angina pectoris—Docetaxel—melanoma	6.98e-05	0.0183	CcSEcCtD
Dopamine—Hypertension—Carmustine—melanoma	6.7e-05	0.0176	CcSEcCtD
Dopamine—Palpitations—Temozolomide—melanoma	6.63e-05	0.0174	CcSEcCtD
Dopamine—Anxiety—Carmustine—melanoma	6.59e-05	0.0173	CcSEcCtD
Dopamine—Hypertension—Temozolomide—melanoma	6.48e-05	0.017	CcSEcCtD
Dopamine—Dyspnoea—Bleomycin—melanoma	6.47e-05	0.017	CcSEcCtD
Dopamine—Anxiety—Temozolomide—melanoma	6.37e-05	0.0167	CcSEcCtD
Dopamine—Tachycardia—Carmustine—melanoma	6.18e-05	0.0162	CcSEcCtD
Dopamine—Dyspnoea—Carmustine—melanoma	5.65e-05	0.0148	CcSEcCtD
Dopamine—Dyspnoea—Temozolomide—melanoma	5.46e-05	0.0143	CcSEcCtD
Dopamine—Vomiting—Bleomycin—melanoma	4.62e-05	0.0121	CcSEcCtD
Dopamine—Palpitations—Docetaxel—melanoma	4.41e-05	0.0116	CcSEcCtD
Dopamine—Nausea—Bleomycin—melanoma	4.31e-05	0.0113	CcSEcCtD
Dopamine—Hypertension—Docetaxel—melanoma	4.31e-05	0.0113	CcSEcCtD
Dopamine—Vomiting—Dactinomycin—melanoma	4.31e-05	0.0113	CcSEcCtD
Dopamine—Vomiting—Carmustine—melanoma	4.03e-05	0.0106	CcSEcCtD
Dopamine—Nausea—Dactinomycin—melanoma	4.02e-05	0.0106	CcSEcCtD
Dopamine—Tachycardia—Docetaxel—melanoma	3.97e-05	0.0104	CcSEcCtD
Dopamine—Headache—Carmustine—melanoma	3.97e-05	0.0104	CcSEcCtD
Dopamine—Vomiting—Temozolomide—melanoma	3.89e-05	0.0102	CcSEcCtD
Dopamine—Headache—Temozolomide—melanoma	3.84e-05	0.0101	CcSEcCtD
Dopamine—Nausea—Carmustine—melanoma	3.76e-05	0.00988	CcSEcCtD
Dopamine—Nausea—Temozolomide—melanoma	3.64e-05	0.00955	CcSEcCtD
Dopamine—Dyspnoea—Docetaxel—melanoma	3.63e-05	0.00953	CcSEcCtD
Dopamine—Vomiting—Docetaxel—melanoma	2.59e-05	0.0068	CcSEcCtD
Dopamine—Headache—Docetaxel—melanoma	2.55e-05	0.0067	CcSEcCtD
Dopamine—Nausea—Docetaxel—melanoma	2.42e-05	0.00635	CcSEcCtD
Dopamine—CYP2C19—Metabolism—PRKCA—melanoma	9.55e-06	2.65e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CB—melanoma	9.54e-06	2.65e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ABCB1—melanoma	9.54e-06	2.65e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CXCL8—melanoma	9.49e-06	2.63e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ERCC2—melanoma	9.47e-06	2.63e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ABCB1—melanoma	9.46e-06	2.63e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—melanoma	9.45e-06	2.63e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—FGF2—melanoma	9.45e-06	2.63e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—MAPK3—melanoma	9.44e-06	2.62e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HRAS—melanoma	9.42e-06	2.62e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1B—melanoma	9.39e-06	2.61e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKT1—melanoma	9.37e-06	2.6e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKT1—melanoma	9.29e-06	2.58e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—PIK3CA—melanoma	9.28e-06	2.58e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—BRAF—melanoma	9.27e-06	2.57e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1B—melanoma	9.26e-06	2.57e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MDM2—melanoma	9.24e-06	2.57e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—melanoma	9.2e-06	2.56e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL2—melanoma	9.19e-06	2.55e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—PIK3CA—melanoma	9.18e-06	2.55e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—melanoma	9.16e-06	2.55e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—melanoma	9.14e-06	2.54e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ERBB2—melanoma	9.11e-06	2.53e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—melanoma	9.08e-06	2.52e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL2—melanoma	9.07e-06	2.52e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—melanoma	9.06e-06	2.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IGF1—melanoma	9.03e-06	2.51e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—melanoma	9.02e-06	2.51e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CB—melanoma	8.99e-06	2.5e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—MAPK1—melanoma	8.98e-06	2.5e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—melanoma	8.98e-06	2.49e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—STAT3—melanoma	8.97e-06	2.49e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCND1—melanoma	8.96e-06	2.49e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NRAS—melanoma	8.95e-06	2.49e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TP53—melanoma	8.88e-06	2.47e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—PIK3CA—melanoma	8.88e-06	2.47e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CTNNB1—melanoma	8.87e-06	2.46e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTEN—melanoma	8.85e-06	2.46e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MDM2—melanoma	8.84e-06	2.46e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCND1—melanoma	8.84e-06	2.45e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PRKCA—melanoma	8.78e-06	2.44e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CTNNB1—melanoma	8.75e-06	2.43e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAP2K1—melanoma	8.72e-06	2.42e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ERBB2—melanoma	8.72e-06	2.42e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ERCC2—melanoma	8.71e-06	2.42e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PRKCA—melanoma	8.7e-06	2.42e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—melanoma	8.7e-06	2.42e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—melanoma	8.67e-06	2.41e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CD—melanoma	8.67e-06	2.41e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CDKN1A—melanoma	8.66e-06	2.41e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.66e-06	2.41e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PTEN—melanoma	8.65e-06	2.4e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CXCL8—melanoma	8.64e-06	2.4e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ERCC2—melanoma	8.63e-06	2.4e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NFKB1—melanoma	8.6e-06	2.39e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CB—melanoma	8.6e-06	2.39e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—STAT3—melanoma	8.59e-06	2.39e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HRAS—melanoma	8.59e-06	2.39e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—PIK3CA—melanoma	8.58e-06	2.38e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—melanoma	8.58e-06	2.38e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK3—melanoma	8.57e-06	2.38e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NRAS—melanoma	8.57e-06	2.38e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CDKN1A—melanoma	8.55e-06	2.37e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PTEN—melanoma	8.53e-06	2.37e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HRAS—melanoma	8.49e-06	2.36e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NFKB1—melanoma	8.49e-06	2.36e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—KRAS—melanoma	8.48e-06	2.36e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1B—melanoma	8.44e-06	2.34e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—melanoma	8.43e-06	2.34e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—melanoma	8.35e-06	2.32e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MYC—melanoma	8.34e-06	2.32e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—melanoma	8.32e-06	2.31e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—FGF2—melanoma	8.3e-06	2.3e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—melanoma	8.27e-06	2.3e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CXCL8—melanoma	8.27e-06	2.3e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL2—melanoma	8.26e-06	2.29e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTEN—melanoma	8.24e-06	2.29e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—melanoma	8.22e-06	2.28e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HRAS—melanoma	8.21e-06	2.28e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK3—melanoma	8.21e-06	2.28e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MAPK1—melanoma	8.16e-06	2.27e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—melanoma	8.15e-06	2.27e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—melanoma	8.13e-06	2.26e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—melanoma	8.13e-06	2.26e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ABCB1—melanoma	8.08e-06	2.24e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1B—melanoma	8.07e-06	2.24e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCND1—melanoma	8.05e-06	2.24e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—melanoma	7.99e-06	2.22e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MYC—melanoma	7.98e-06	2.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CTNNB1—melanoma	7.97e-06	2.21e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—melanoma	7.91e-06	2.2e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL2—melanoma	7.9e-06	2.19e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—melanoma	7.86e-06	2.18e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.84e-06	2.18e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—melanoma	7.82e-06	2.17e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—melanoma	7.81e-06	2.17e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MAPK1—melanoma	7.81e-06	2.17e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—melanoma	7.81e-06	2.17e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—PIK3CA—melanoma	7.8e-06	2.17e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CDKN1A—melanoma	7.79e-06	2.16e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PTEN—melanoma	7.77e-06	2.16e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MDM2—melanoma	7.76e-06	2.16e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NFKB1—melanoma	7.73e-06	2.15e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—STAT3—melanoma	7.73e-06	2.15e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NRAS—melanoma	7.71e-06	2.14e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—melanoma	7.7e-06	2.14e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KRAS—melanoma	7.7e-06	2.14e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCND1—melanoma	7.7e-06	2.14e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ERBB2—melanoma	7.65e-06	2.13e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—STAT3—melanoma	7.63e-06	2.12e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CTNNB1—melanoma	7.63e-06	2.12e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NRAS—melanoma	7.61e-06	2.11e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—melanoma	7.58e-06	2.11e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CB—melanoma	7.55e-06	2.1e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—melanoma	7.5e-06	2.08e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—melanoma	7.48e-06	2.08e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CG—melanoma	7.48e-06	2.08e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CDKN1A—melanoma	7.45e-06	2.07e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PRKCA—melanoma	7.44e-06	2.07e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PTEN—melanoma	7.43e-06	2.06e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NFKB1—melanoma	7.4e-06	2.06e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK3—melanoma	7.39e-06	2.05e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—PIK3CA—melanoma	7.38e-06	2.05e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ERCC2—melanoma	7.38e-06	2.05e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KRAS—melanoma	7.37e-06	2.05e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK3—melanoma	7.29e-06	2.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CXCL8—melanoma	7.26e-06	2.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—melanoma	7.25e-06	2.01e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARG—melanoma	7.22e-06	2e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HRAS—melanoma	7.21e-06	2e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MYC—melanoma	7.18e-06	2e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.15e-06	1.99e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MYC—melanoma	7.09e-06	1.97e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1B—melanoma	7.09e-06	1.97e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—PIK3CA—melanoma	7.08e-06	1.97e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MAPK1—melanoma	7.03e-06	1.95e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—melanoma	7.03e-06	1.95e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—melanoma	7.02e-06	1.95e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—melanoma	7.01e-06	1.95e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—STAT3—melanoma	6.95e-06	1.93e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—melanoma	6.95e-06	1.93e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL2—melanoma	6.94e-06	1.93e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MAPK1—melanoma	6.93e-06	1.93e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NRAS—melanoma	6.93e-06	1.93e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—melanoma	6.93e-06	1.93e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—melanoma	6.9e-06	1.92e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CG—melanoma	6.88e-06	1.91e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TP53—melanoma	6.85e-06	1.9e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CG—melanoma	6.82e-06	1.89e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—PIK3CA—melanoma	6.77e-06	1.88e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCND1—melanoma	6.76e-06	1.88e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—melanoma	6.71e-06	1.87e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CTNNB1—melanoma	6.7e-06	1.86e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—STAT3—melanoma	6.65e-06	1.85e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK3—melanoma	6.64e-06	1.84e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KRAS—melanoma	6.64e-06	1.84e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARG—melanoma	6.64e-06	1.84e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NRAS—melanoma	6.63e-06	1.84e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARG—melanoma	6.58e-06	1.83e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CD—melanoma	6.57e-06	1.83e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—melanoma	6.57e-06	1.82e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TP53—melanoma	6.55e-06	1.82e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KRAS—melanoma	6.55e-06	1.82e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HRAS—melanoma	6.55e-06	1.82e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CDKN1A—melanoma	6.54e-06	1.82e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PTEN—melanoma	6.53e-06	1.81e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NFKB1—melanoma	6.5e-06	1.8e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALB—melanoma	6.49e-06	1.8e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MYC—melanoma	6.46e-06	1.79e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—melanoma	6.37e-06	1.77e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK3—melanoma	6.35e-06	1.76e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MAPK1—melanoma	6.32e-06	1.76e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—melanoma	6.32e-06	1.75e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HRAS—melanoma	6.27e-06	1.74e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—melanoma	6.27e-06	1.74e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3CA—melanoma	6.24e-06	1.73e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MYC—melanoma	6.18e-06	1.72e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.11e-06	1.7e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3CA—melanoma	6.1e-06	1.69e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CD—melanoma	6.05e-06	1.68e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MAPK1—melanoma	6.04e-06	1.68e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—melanoma	6.04e-06	1.68e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—melanoma	6.03e-06	1.67e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3CA—melanoma	6.02e-06	1.67e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—melanoma	6e-06	1.67e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CD—melanoma	5.99e-06	1.66e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KRAS—melanoma	5.97e-06	1.66e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALB—melanoma	5.97e-06	1.66e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALB—melanoma	5.92e-06	1.64e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TP53—melanoma	5.9e-06	1.64e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—melanoma	5.9e-06	1.64e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—STAT3—melanoma	5.84e-06	1.62e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CG—melanoma	5.83e-06	1.62e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NRAS—melanoma	5.82e-06	1.62e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TP53—melanoma	5.82e-06	1.62e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3CA—melanoma	5.82e-06	1.62e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—melanoma	5.78e-06	1.61e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CB—melanoma	5.73e-06	1.59e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KRAS—melanoma	5.71e-06	1.59e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—melanoma	5.68e-06	1.58e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HRAS—melanoma	5.64e-06	1.57e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARG—melanoma	5.62e-06	1.56e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK3—melanoma	5.58e-06	1.55e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HRAS—melanoma	5.57e-06	1.55e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—melanoma	5.53e-06	1.54e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3CA—melanoma	5.48e-06	1.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MYC—melanoma	5.42e-06	1.51e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—melanoma	5.4e-06	1.5e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—melanoma	5.33e-06	1.48e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MAPK1—melanoma	5.31e-06	1.47e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—melanoma	5.31e-06	1.47e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TP53—melanoma	5.3e-06	1.47e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CB—melanoma	5.27e-06	1.46e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3CA—melanoma	5.24e-06	1.46e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CB—melanoma	5.22e-06	1.45e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—melanoma	5.22e-06	1.45e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—melanoma	5.18e-06	1.44e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CD—melanoma	5.12e-06	1.42e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—melanoma	5.1e-06	1.42e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TP53—melanoma	5.07e-06	1.41e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HRAS—melanoma	5.07e-06	1.41e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALB—melanoma	5.06e-06	1.4e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KRAS—melanoma	5.01e-06	1.39e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—melanoma	4.98e-06	1.38e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTEN—melanoma	4.95e-06	1.38e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—melanoma	4.92e-06	1.37e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—melanoma	4.86e-06	1.35e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HRAS—melanoma	4.85e-06	1.35e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—melanoma	4.75e-06	1.32e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—melanoma	4.64e-06	1.29e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3CA—melanoma	4.6e-06	1.28e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTEN—melanoma	4.55e-06	1.26e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTEN—melanoma	4.51e-06	1.25e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—melanoma	4.48e-06	1.24e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CB—melanoma	4.46e-06	1.24e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TP53—melanoma	4.45e-06	1.24e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—melanoma	4.42e-06	1.23e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—melanoma	4.28e-06	1.19e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HRAS—melanoma	4.26e-06	1.18e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—melanoma	4.08e-06	1.13e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTEN—melanoma	3.86e-06	1.07e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—melanoma	3.76e-06	1.04e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3CA—melanoma	3.49e-06	9.7e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3CA—melanoma	3.21e-06	8.92e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3CA—melanoma	3.18e-06	8.85e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—melanoma	2.85e-06	7.92e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3CA—melanoma	2.72e-06	7.56e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—melanoma	2.62e-06	7.29e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—melanoma	2.6e-06	7.23e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—melanoma	2.22e-06	6.17e-06	CbGpPWpGaD
